A fair enough statement:
&quot;The broader availability of [over-the-counter] insulin allows patients with diabetes to obtain it &quot;quickly in urgent situations, without delays,&quot; the FDA says, and is intended to increase patient safety.&quot;<p>However, it seems like there are no visible protocols in place to control use in non-emergency situations like with the patient mentioned in the NYTimes article. That&#x27;s certainly risky for poorer diabetics who don&#x27;t necessarily know better, or are desperate enough financially to risk the long-term consequences.